UAE Dermatological Therapeutics Market Analysis Report 2022 to 2030

UAE Dermatological Therapeutics Market Analysis

$ 3999

UAE Dermatological Therapeutics Market is at around $0.21 Bn in 2023 and is projected to reach $0.39 Bn in 2030, exhibiting a CAGR of 9.6% during the forecast period. The market is being driven by advancements in dermatological research, medical tourism, and growing awareness of skin health. The market is dominated by key players like Neopharma, Julphur, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.

ID: IN10AEPH035 CATEGORY: Pharmaceuticals GEOGRAPHY: UAE AUTHOR: Aneri Parekh

Buy Now

UAE Dermatological Therapeutics Market Executive Summary

UAE Dermatological Therapeutics Market is at around $0.21 Bn in 2023 and is projected to reach $0.39 Bn in 2030, exhibiting a CAGR of 9.6% during the forecast period.

Dermatological therapy involves medical and cosmetic methods used in the diagnosis and treatment of skin problems. Dermatologists treat disorders like acne, eczema, and skin cancer with a variety of methods, such as topical drugs, laser therapy, and surgical operations. The field stresses a comprehensive approach, taking into account UAE-specific environmental and cultural aspects. Dermatological treatments in the nation are distinguished by cutting-edge technologies and global benchmarks, guaranteeing thorough and efficient treatment for a wide range of skin problems. In the United Arab Emirates, dermatologists and other medical experts frequently collaborate, which supports a multidisciplinary approach to skin health.

The dermatological market in the United Arab Emirates is expanding rapidly due to rising knowledge of skincare and cosmetics. Growing income is driving up demand for innovative dermatological treatments and cosmetic surgeries. Modern technologies are being innovated by leading companies in the industry to meet a variety of skincare needs. The United Arab Emirates continues to be a leading center for dermatological treatments and breakthroughs, because of its thriving beauty and wellness sector.

With $40.94 Bn in revenue, the worldwide market for dermatological treatments had a startling boom in 2023. This enormous growth is an indication of a changing world with cutting-edge technologies and incredibly efficient production methods. A mix of increased funding, continuous innovation, and more accessibility is driving the industry's rapid growth. The market for dermatological treatments has benefited from this confluence of factors, which has also helped to position the sector as growing and establishing.

Neopharma was able to create a strong local presence, a varied product portfolio, and strategic alliances to gain a leading position in the UAE's dermatological therapies industry. It boasts a thorough awareness of the cultural tastes and market needs of the United Arab Emirates, allowing them to meet particular local requests. It supplies a selection of creams, ointments, and lotions for common skin disorders like acne, eczema, and psoriasis. In the UAE market, their brands, such as Eumovate and Topilene, are highly recognized.

UAE dermatological therapeutics market

Market Dynamics

Market Growth Drivers:

Growing Knowledge of Skin Health: Need for dermatological therapies is fuelled by growing knowledge of the value of skin care and general skin health. Patients look for remedies and preventative strategies for different skin diseases.

Developments in Dermatological Research: The market can increase as a result of ongoing dermatological research and development that produces novel and more potent medicinal treatments. Both patients and medical personnel may be drawn to new technologies and treatment approaches.

Medical Tourism: The United Arab Emirates has been at the forefront of promoting medical tourism, with many foreign patients seeking dermatological treatments. The market for dermatological therapies may expand as a result of the ongoing improvements in healthcare facilities and services.

Market Restraints:

Health Insurance Coverage: The degree to which dermatological therapies are covered by health insurance may have an impact on patient affordability and, in turn, the demand for medicines in the market.

Cultural Considerations: Acceptance and application of specific dermatological products or treatments may be influenced by cultural conventions and preferences.

Strict Laws and Licensing Requirements: In the United Arab Emirates, getting approval for new medications and treatments can be a time-consuming and costly procedure. This may deter producers from releasing cutting-edge goods on the market.

Healthcare Policies and Regulatory Landscape

The Ministry of Health and Prevention (MoHAP) of the United Arab Emirates (UAE) is in charge of overseeing pharmaceutical regulations. The procedure includes filing the request online via the MoHAP website, satisfying all conditions, paying the necessary charges, and then forwarding the report to the relevant ministerial committee. To get a drug approved, compliance with Good Manufacturing Practices (GMP) is essential. Adherence to stringent quality standards is crucial for pharmaceutical manufacturing facilities to ensure product consistency and quality, thereby complicating the process.

Competitive Landscape

Key Players:

Neopharma
Julphar
Almirall SA
Pfizer Inc.
AbbVie Inc.
Amgen
Gladerma SA
Johnson & Johnson
Novartis AG
Eli Lily and Company
Sun Pharmaceuticals Ltd.
GlaxoSmithKline PLC

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

UAE Dermatological Therapeutics Market Segmentation

By Type

Prescription-based Drugs
Over-the-counter Drugs

By Disease

Alopecia
Herpes
Psoriasis
Rosacea
Skin Cancer
Acne
Atopic Dermatitis
Vitiligo
Hidradenitis
Other Applications

By Drug Class

Anti-infectives
Corticosteroids
Anti-acne
Calcineurin Inhibitors
Retinoids
Other Drug Classes

By Route of Administration

Topical Administration
Oral Administration
Parenteral Administration

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.